SingleFlowEx CD79b FITC
CAT:
270-ED7593
Size:
1 mL
Price:
Ask
- Availability: 24/48H Stock Items & 2 to 6 Weeks non Stock Items.
- Dry Ice Shipment: No

SingleFlowEx CD79b FITC
- Description: SingleFlowEx is fluorochrome-labeled monoclonal antibody single reagent for use in laboratory-developed multicolor flow cytometry tests in order to examine human clinical samples. SingleFlowEx can be used in various multicolor combinations. Laboratory shall establish the SingleFlowEx performance characteristics in conjunction with other reagents in normal and pathological samples.
- Certification: RUO, GMP
- Clone: CB3-1
- Validated Applications: FC
- Concentration: 0.100 mg/mL
- Format: FITC
- Buffer: Stabilizing phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Components: 1 vial of monoclonal antibody reagent. The content (1 mL) is sufficient for min. 100 Tests.
- References & Citations: *Nakamura T, Kubagawa H, Cooper MD: Heterogeneity of immunoglobulin-associated molecules on human B cells identified by monoclonal antibodies. Proc Natl Acad Sci U S A. 1992 Sep 1589(18):8522-6., URL: https://www.ncbi.nlm.nih.gov/pubmed/1382292,*Zheng B, Fuji RN, Elkins K, Yu SF, Fuh FK, Chuh J, Tan C, Hongo JA, Raab H, Kozak KR, Williams M, McDorman E, Eaton D, Ebens A, Polson AG: In vivo effects of targeting CD79b with antibodies and antibody-drug conjugates. Mol Cancer Ther. 2009 Oct8(10):2937-46., URL: https://www.ncbi.nlm.nih.gov/pubmed/19808977,*Garcia Vela J, Delgado I, Benito L, Monteserin M, Garcia Alonso L, Somolinos N, Andreu M, Oña F: CD79b expression in B cell chronic lymphocytic leukemia: its implication for minimal residual disease detection. Leukemia. 1999 Oct13(10):1501-5., URL: https://www.ncbi.nlm.nih.gov/pubmed/10516749,*Rassenti LZ, Kipps TJ: Expression of Ig-beta (CD79b) by chronic lymphocytic leukemia B cells that lack immunoglobulin heavy-chain allelic exclusion. Blood. 2000 Apr 1595(8):2725-7., URL: https://www.ncbi.nlm.nih.gov/pubmed/10753858,*Dornan D, Bennett F, Chen Y, Dennis M, Eaton D, Elkins K, French D, Go MA, Jack A, Junutula JR, Koeppen H, Lau J, McBride J, Rawstron A, Shi X, Yu N, Yu SF, Yue P, Zheng B, Ebens A, Polson AG: Therapeutic potential of an anti-CD79b antibody-drug conjugate, anti-CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma. Blood. 2009 Sep 24114(13):2721-9., URL: https://www.ncbi.nlm.nih.gov/pubmed/19633198,*Matutes E: New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Clin Pathol. 2002 Mar55(3):180-3., URL: http://www.ncbi.nlm.nih.gov/pubmed/11896067 ,*D'Arena G, Cascavilla N, Musto P, Colella Bisogno R, Pistolese G, Carotenuto M: CD79b expression in B-cell chronic lymphocytic leukemia. Haematologica. 2000 May85(5):556-7., URL: http://www.ncbi.nlm.nih.gov/pubmed/10800181 ,*Use of this product has not been published., URL: ,
- Storage Conditions: Store at 2-8°C. Protect from prolonged exposure to light. Do not freeze.